SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-20-000427
Filing Date
2020-02-10
Accepted
2020-02-10 14:30:06
Documents
3
Period of Report
2020-01-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cannapharmarx_8k.htm 8-K 20687
2 FORM OF NOTES cannapharmarx_ex0401.htm EX-4.1 150316
3 FORM OF SECURITIES PURCHASE AGREEMENT cannapharmarx_ex1001.htm EX-10.1 173496
  Complete submission text file 0001683168-20-000427.txt   346047
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

IRS No.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27055 | Film No.: 20591383
SIC: 2834 Pharmaceutical Preparations